400
Participants
Start Date
February 6, 2022
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2025
Imatinib
Oral imatinib 400 mg tablet once a day for 14 days.
Infliximab
Infliximab is administered as a single IV infusion with the proposed dosing schedule of 5 mg/kg body weight.
RECRUITING
University of Helsinki, Helsinki
University of Helsinki
OTHER
World Health Organization
OTHER
Helsinki University Central Hospital
OTHER
Hyvinkää Hospital
OTHER
Kanta-Häme Central Hospital
OTHER_GOV
Kuopio University Hospital
OTHER
City of Helsinki
OTHER
Oulu University Hospital
OTHER
Porvoo Hospital
UNKNOWN
Seinajoki Central Hospital
OTHER
Mikkeli Central Hospital
OTHER
Tampere University Hospital
OTHER
Clinical Urology and Epidemiology Working Group
OTHER_GOV